Evaluation of antibacterial activity of Australian basidiomycetous macrofungi using a high-throughput 96-well plate assay

Pharmaceutical Biology

Volumn 49, Issue 5, 2011, Pages 492-500

  Bala, Neeraj ^a   Aitken, Elizabeth A B ^a   Fechner, Nigel ^a,b   Cusack, Andrew ^c   Steadman, Kathryn J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND HERBARIUM   (Australia)

^c DEPARTMENT OF EMPLOYMENT ECONOMIC DEVELOPMENT AND INNOVATION   (Australia)

Author keywords

96 well plate assay; antibacterial; E. coli; Fungi; S. aureus; water extracts

Indexed keywords

ANTIINFECTIVE AGENT; BASIDIOMYCETES EXTRACT; UNCLASSIFIED DRUG;

AGARICUS; AMANITA; ANTIBACTERIAL ACTIVITY; ARTICLE; AUSTRALIA; BACTERIAL GROWTH; BASIDIOMYCETES; CANTHARELLUS; CONCENTRATION RESPONSE; CORIOLACEAE; DRUG SCREENING; ESCHERICHIA COLI; FUNGUS; GROWTH INHIBITION; HOHENBUEHELIA; LENTINUS; MUSHROOM; NONHUMAN; RAMARIA; STAPHYLOCOCCUS AUREUS; STROBILOMYCES;

ANTI-BACTERIAL AGENTS; AUSTRALIA; BASIDIOMYCOTA; ESCHERICHIA COLI; HIGH-THROUGHPUT SCREENING ASSAYS; STAPHYLOCOCCUS AUREUS;

AGARICACEAE; AGARICUS; AMANITA; AMANITACEAE; BACTERIA (MICROORGANISMS); BOLETACEAE; BOLETUS; CANTHARELLACEAE; CANTHARELLUS; ESCHERICHIA COLI; FOMITOPSIS; FUNGI; GOMPHACEAE; HOHENBUEHELIA; LENTINUS; PLEUROTACEAE; POLYPORACEAE; RAMARIA; STAPHYLOCOCCUS AUREUS; STROBILOMYCES;

EID: 79955052350     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.526616     Document Type: Article

References (47)

1. Al-Fatimi MA, Jülich WD, Jansen R, Lindequist U. (2006). Bioactive components of the traditionally used mushroom Podaxis pistillaris. Evid Based Complement Alternat Med 3:87-92. (Pubitemid 43999656)
2. Alfonso JA. (2005). Resistance toantibiotics: Are we in the postantibiotic era? Arch Med Res 36:697-705.
3. Barros L, Calhelha RC, Vaz JA, Ferreira I, Baptista P, Estevinho LM. (2007). Antimicrobial activity and bioactive compounds of Portuguese wild edible mushrooms methanolic extracts. Eur Food Res Tech 225:151-156. (Pubitemid 46707774)
4. Barros L, Venturini BA, Baptista P, Estevinho LM, Ferreira IC. (2008). Chemical composition and biological properties of Portuguese wild mushrooms: A comprehensive study. J Agric Food Chem 56:3856-3862. (Pubitemid 351860194)
5. Beattie KD, Rouf R, Gander L, May TW, Ratkowsky D, Donner CD, Gill M, Grice ID, Tiralongo E. (2010). Antibacterial metabolites from Australian macrofungi from the genus Cortinarius. Phytochemistry 71:948-955.
6. Boa E. (2004). Wild edible fungi a global overview of their use and importance to people. Non-Wood Forest Products 17. Rome, Italy:FAO.
7. Chang ST, Buswell JA. (1996). Mushroom nutriceuticals. World J Microbiol Biotech 12:473-476. (Pubitemid 26370085)
8. Costerton JW, Cheng KJ. (1975). The role of the bacterial cell envelope in antibiotic resistance. J Antimicrob Chemother 1:363-377.
9. Drews J, Georgopoulos A, Laber G, Schütze E, Unger J. (1975). Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative. Antimicrob Agents Chemother 7:507-516.
10. Dulger B. (2004). Antimicrobial activity of the macrofungus Pholiota adiposa. Fitoterapia 75:395-397. (Pubitemid 38670577)
11. Dulger B, Gonuz A, Gucin F. (2004). Antimicrobial activity of the macrofungus Cantharellus cibarius. Pak J Biol Sci 7:1535-1539.
12. Efremenkova OV, Ershova EY, Tolstych IV, Zenkova VA, Dudnik YV. (2003). Antimicrobial activity of medicinal mushrooms from the genus Coprinus (Fr.) S. F. Gray (Agaricomycetedeae). Int J Med Mush 5:37-41.
13. Fleming A. (1929). On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 10:226-236.
14. Gbolagade J, Kigigha L, Ohimain E. (2007). Antagonistic effects of extracts of some Nigerian higher fungi against selected pathogenic microorganisms. Am-Eurasian J Agric Environ Sci 2:364-368.
15. Gezer K, Duru ME, Kivrak I, Turkoglu A, Mercan N, Turkoglu H, Gulcan S. (2006). Free-radical scavenging capacity and antimicrobial activity of wild edible mushroom from Turkey. Afr J Biotech 5:1924-1928. (Pubitemid 44736968)
16. Hannan PC, Windsor HM, Ripley PH. (1997). In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res Vet Sci 63:157-160.
17. Hawksworth DL. (2001). Mushrooms: The extent of the unexplored potential. Int J Med Mush 3:333-337.
18. Hunt E. (2000). Pleuromutilin antibiotics. Drugs Fut 25:1163-1168. (Pubitemid 32094765)
19. Infectious Diseases Society of America. (2010). The 10 × '20 Initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 50:1081-1083.
20. Iwalokun BA, Usen UA, Otunba AA, Olukoya DK. (2007). Comparative phytochemical evaluation, antimicrobial and antioxidant properties of Pleurotus ostreatus. Afr J Biotech 6:1732-1739. (Pubitemid 47292773)
21. Janes D, Kreft S, Jurc M, Seme K, Strukelj B. (2007). Antibacterial activity in higher fungi (mushrooms) and endophytic fungi from Slovenia. Pharm Biol 45:700-706. (Pubitemid 350125764)
22. Jonathan SG, Fasidi IO. (2003). Antimicrobial activities of two Nigerian edible macrofungi Lycoperdon pusilum (Bat. Ex) and Lycoperdon giganteum (Pers.). Afr J Biomed Res 6:85-90.
23. Jones RN, Fritsche TR, Sader HS, Ross JE. (2006). Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci. Antimicrob Agents Chemother 50: 2583-2586. (Pubitemid 43993211)
24. Jones RN, Pfaller MA, Rhomberg PR, Walter DH. (2002). Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods. J Clin Microbiol 40:461-465. (Pubitemid 34130868)
25. Kalotas AC. (1996). Aboriginal knowledge and use of fungi. Fungi Aust 1B:268-295.
26. Karaman M, Mimica-Dukic N, Knežević P, Svirčev Z, Matavuly M. (2009). Antibacterial properties of selected lignicolous mushrooms and fungi from northern Serbia. Int J Med Mush 11:269-279.
27. Kavanagh F, Hervey A, Robbins WJ. (1951). Antibiotic substances from Basidiomycetes: VIII. Pleurotus multilus (Fr.) Sacc. and Pleurotus passeckerianus Pilat. Proc Natl Acad Sci USA 37:570-574.
28. Keller C, Maillard M, Keller J, Hostettmann K. (2002). Screening of European fungi for antibacterial, antifungal, larvicidal, molluscicidal, antioxidant and free-radical scavenging activities and subsequent isolation of bioactive compounds. Pharm Biol 40:518-525. (Pubitemid 36801717)
29. Levy SB, Marshall B. (2004). Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10:S122-S129. (Pubitemid 40018235)
30. Lindequist U, Niedermeyer TH, Jülich WD. (2005). The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2:285-299. (Pubitemid 41258148)
31. Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott M, Monte A. (2010). Antibacterial compounds from mushrooms II: lanostane triterpenoids and an ergostane steroid with activity against Bacillus cereus isolated from Fomitopsis pinicola. Planta Med 76: 464-466.
32. Lund RG, Del Pino FAB, Serpa R, Nascimento JSD, DA Silva VM, Ribeiro GA, Rosalen PL. (2009). Antimicrobial activity of ethanol extracts of Agaricus brasiliensis against mutans streptococci. Pharm Biol 47:910-915.
33. May TW. (2003). The status of names and records of Australian macrofungi. N Z J Bot 41:379-389. (Pubitemid 38062115)
34. Molitoris HP. (1994). Mushrooms in medicine. Folia Microbiol (Praha) 39:91-98.
35. Novak R, Shlaes DM. (2010). The pleuromutilin antibiotics: A new class for human use. Curr Opin Investig Drugs 11:182-191.
36. Ovenden SP, Yu J, Bernays J, Wan SS, Christophidis LJ, Sberna G, Tait RM, Wildman HG, Lebeller D, Platel D, May TW, Meurer- Grimes BM. (2005). Cerylimycins [corrected] A and B: Antibacterial triterpenes from the new species Tricholoma sp. AU1. J Nat Prod 68:409-412. (Pubitemid 40545481)
37. Popova M, Trusheva B, Gyosheva M, Tsvetkova I, Bankova V. (2009). Antibacterial triterpenes from the threatened wood-decay fungus Fomitopsis rosea. Fitoterapia 80:263-266.
38. Santoyo S, Ramirez-Anguiano AC, Reglero G, Soler-Rivas C. (2009). Improvement of the antimicrobial activity of edible mushroom extracts by inhibition of oxidative enzymes. Int J Food Sci Technol 44:1057-1064.
39. Stamets P. (2006). Can mushrooms help save the world? Explore 2:152-161.
40. Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Díez MT, García JB, del Val AG, Gorrochategui J, Hernández P, Peláez F, Vicente MF. (2000). Screening of basidiomycetes for antimicrobial activities. Antonie Van Leeuwenhoek 78:129-139. (Pubitemid 32046755)
41. Sultanbawa Y, Cusack A, Currie M, Davis C. (2009). An innovative microplate assay to facilitate the detection of antimicrobial activity in plant extracts. J Rapid Meth Auto Microbiol 17: 519-534.
42. Tambekar DH, Sonar TP, Khodke MV, Khante BS. (2006). The novel antimicrobials from two edible mushrooms: Agaricus bisporus and Pleurotus sajor caju. Int J Pharmacol 2:584-587.
43. Walsh C. (2003). Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press, p. 26.
44. Wasser SP, Weis AL. (1999). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 19:65-96. (Pubitemid 29062102)
45. Werner H, Laber G, Schütze E, Krasemann C, May P. (1978). In vitro activity of tiamulin (81.723 HFU), a new pleuromulin derivative, against clinically significant anaerobes. J Antibiot 31:756-760. (Pubitemid 9037381)
46. Xu P, Zhang YY, Sun YX, Liu JH, Yang B, Wang YZ, Wang YL. (2009). Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus. Chem Biol Drug Des 73:655-660.
47. Yamac M, Bilgili F. (2006). Antimicrobial activities of fruit bodies and/or mycelial cultures of some mushroom isolates. Pharm Biol 44:660-667. (Pubitemid 44847001)